Log In | Register
A new study published in the journal Lancet Oncology, is reporting the potential for increased risk for cancer associated with the use of the blood pressure medication Micardis (telmisartan), an angiotensin receptor blocker (ARB) made by Boehringer Ingelheim.
Blood Pressure Medication May Pose Cancer Risk
Seeded on Sat Jul 24, 2010 9:38 AM EDT
Article Source: Lawyers and Settlements- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
According to a report on Reuters.com, Dr. Ilke Sipahi and colleagues from Case Western Reserve University in Cleveland and colleagues wrote in the journal Lancet Oncology, "The increased risk of new cancer occurrence is modest but significant."
#1 - Sat Jul 24, 2010 9:39 AM EDTYou're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
